According to our results, we expect that CPO will have potential applications not only to HCC but also to various metabolic diseases caused by obesity because CPO affected the point mutation at the same position in the studied Huh7 cells. Here, CPO is linked to obesity due to melanocortin 4 receptor deficiency.